FDA Grants Breakthrough Device Designation for nQ Medical’s neuroQWERTY
News
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to nQ Medical’s neuroQUERTY software, which is designed to monitor brain health and Parkinson’s disease progression. Breakthrough device status ... Read more